47 results
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
of its obligations hereunder and to the continuing satisfaction of the additional conditions specified in Section 6 of this Agreement.
(ix)If the Company
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Jan 24
Current report (foreign)
7:43am
and the satisfaction of liabilities and commitments in the ordinary course of business.
Liquidity is the ability of a company to generate funds … of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.
Liquidity
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Current report (foreign)
4:06pm
of the preceding Article, evidence to the satisfaction of the Directors of the authority of the person claiming to exercise the right to vote must
6-K
EX-99.4
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
.
12.14 For the purpose of the preceding Article, evidence to the satisfaction of the Directors of the authority of the person claiming to exercise
6-K
EX-99.3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
” shall mean the satisfaction of any one or more of the following conditions (and the “Change of Control” shall be deemed to have occurred … granted under Article XII of the Plan under which, upon the satisfaction of predetermined Performance Goals, Shares are paid to the Holder.
2.31
6-K
EX-10.1
8j1jv
12 Oct 23
Current report (foreign)
8:00am
6-K
dq25xug4tp lzvd
12 Oct 23
Current report (foreign)
8:00am
6-K
EX-4.1
numu1 hajmn5
12 Oct 23
Current report (foreign)
8:00am
6-K
EX-10.1
6f63zqb ov7
1 Sep 23
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
7:37am
6-K
yng ofxgm1081ucq
21 Apr 23
Current report (foreign)
4:30pm
6-K
EX-10.1
ate5pc
18 Nov 22
Current report (foreign)
5:20pm
6-K
EX-10.1
1r7qvhafr oibyc
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-99.1
yqm3g7mc xtgw50egf
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-10.2
d8oy7jxl1mn070ohzozf
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-10.4
7llfc
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
20-F
c76z g16v
12 Aug 22
Annual report (foreign)
4:20pm
6-K
EX-1.1
rrwwhltw1j2
26 Jul 22
Current report (foreign)
7:36am